Comparison of Circulating Plasma DNA Levels between Lung Cancer Patients and Healthy Controls
Authors:
- Sohee ParkSPSohee Park
- Sang Hee LeeSLSang Hee Lee
- Jin Hee KimJKJin Hee Kim
- Jin Soo LeeJLJin Soo Lee
- 1 May 2009
- journal article
- research article
- Published by Elsevier in The Journal of Molecular Diagnostics
- Vol. 11 (3) , 182-185
Abstract
No abstract availableKeywords
This publication has 18 references indexed in Scilit:
- Circulating free DNA in plasma or serum as biomarker of carcinogenesis: Practical aspects and biological significanceMutation Research - Reviews in Mutation Research, 2007
- Quantitative Plasma Hypermethylated DNA Markers of Undifferentiated Nasopharyngeal CarcinomaClinical Cancer Research, 2004
- Quantification of Free Circulating DNA As a Diagnostic Marker in Lung CancerJournal of Clinical Oncology, 2003
- p16(INK4A) Hypermethylation detected by fluorescent methylation-specific PCR in plasmas from non-small cell lung cancer.2002
- Detection of p16 hypermethylation in circulating plasma DNA of non-small cell lung cancer patientsCancer Letters, 2002
- Circulating DNA: a new diagnostic gold mine?Cancer Treatment Reviews, 2002
- About the possible origin and mechanism of circulating DNAClinica Chimica Acta, 2001
- p53 mutation in plasma DNA and its prognostic value in breast cancer patients.2001
- Microsatellite alterations and TP53 mutations in plasma DNA of small-cell lung cancer patients: Follow-up study and prognostic significanceAnnals of Oncology, 2000
- The Origin and Mechanism of Circulating DNAAnnals of the New York Academy of Sciences, 2000